Cargando…
Recent progress in microneme-based vaccines development against Toxoplasma gondii
Toxoplasmosis is a cosmopolitan zoonotic disease, which infect several warm-blooded mammals. More than one-third of the human population are seropositive worldwide. Due to the high seroprevalence of Toxoplasma gondii infection worldwide, the resulting clinical, mental, and economical complications,...
Autores principales: | Foroutan, Masoud, Zaki, Leila, Ghaffarifar, Fatemeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Vaccine Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082678/ https://www.ncbi.nlm.nih.gov/pubmed/30112348 http://dx.doi.org/10.7774/cevr.2018.7.2.93 |
Ejemplares similares
-
Rhomboid antigens are promising targets in the vaccine development against Toxoplasma gondii
por: Foroutan, Masoud, et al.
Publicado: (2019) -
Calcium-dependent protein kinases are potential targets for Toxoplasma gondii vaccine
por: Foroutan, Masoud, et al.
Publicado: (2018) -
Rhoptry antigens as Toxoplasma gondii vaccine target
por: Foroutan, Masoud, et al.
Publicado: (2019) -
Assessment of DNA vaccine encoding Toxoplasma gondii microneme complete gene and IL-12 as adjuvant in BALB/c mice
por: Ghaffarifar, Fatemeh, et al.
Publicado: (2019) -
Synergistic role of micronemal proteins in Toxoplasma gondii virulence
por: Cérède, Odile, et al.
Publicado: (2005)